CS175498B2 - - Google Patents

Info

Publication number
CS175498B2
CS175498B2 CS5170A CS517075A CS175498B2 CS 175498 B2 CS175498 B2 CS 175498B2 CS 5170 A CS5170 A CS 5170A CS 517075 A CS517075 A CS 517075A CS 175498 B2 CS175498 B2 CS 175498B2
Authority
CS
Czechoslovakia
Application number
CS5170A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS175498B2 publication Critical patent/CS175498B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CS5170A 1974-08-05 1975-07-22 CS175498B2 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CS175498B2 true CS175498B2 (OSRAM) 1977-05-31

Family

ID=5922668

Family Applications (2)

Application Number Title Priority Date Filing Date
CS215A CS175500B2 (OSRAM) 1974-08-05 1975-07-22
CS5170A CS175498B2 (OSRAM) 1974-08-05 1975-07-22

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS215A CS175500B2 (OSRAM) 1974-08-05 1975-07-22

Country Status (17)

Country Link
US (1) US4029777A (OSRAM)
JP (1) JPS5141347A (OSRAM)
AT (1) AT345998B (OSRAM)
BE (1) BE832124A (OSRAM)
CA (1) CA1037027A (OSRAM)
CH (1) CH611910A5 (OSRAM)
CS (2) CS175500B2 (OSRAM)
DD (1) DD120192A5 (OSRAM)
DE (1) DE2438020A1 (OSRAM)
DK (1) DK136369C (OSRAM)
ES (1) ES439720A1 (OSRAM)
FR (1) FR2281123A1 (OSRAM)
GB (1) GB1512258A (OSRAM)
HU (1) HU171684B (OSRAM)
IL (1) IL47770A (OSRAM)
NL (1) NL7509326A (OSRAM)
SE (1) SE404804B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
AU609927B2 (en) * 1987-08-25 1991-05-09 Kelvin W. Gee Compositions and methods for alleviating stress, anxiety and seizure activity
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
EP2986623B1 (en) 2013-04-17 2018-11-07 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
SI2986624T1 (sl) 2013-04-17 2020-10-30 Sage Therapeutics, Inc. 19-nor nevroaktivni steroidi za metode zdravljenja
SI3021852T1 (sl) 2013-07-19 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
JP6466942B2 (ja) 2013-08-23 2019-02-06 セージ セラピューティクス, インコーポレイテッド 向神経活性ステロイド、組成物、及びその使用
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP4527461A3 (en) 2014-10-16 2025-06-25 Sage Therapeutics, Inc. A compound, compositions thereof and this compound for use in methods of treating cns disorders
RS60642B1 (sr) 2014-10-16 2020-09-30 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
SMT202000276T1 (it) 2014-11-27 2020-07-08 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
SMT202100113T1 (it) 2015-01-26 2021-05-07 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
NZ790187A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C7, C12, and C16 substituted neuroactive steroids and their methods of use
IL264129B2 (en) 2016-07-11 2024-05-01 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
MA51315A (fr) * 2017-12-22 2020-10-28 Sage Therapeutics Inc Compositions et méthodes permettant de traiter des troubles du snc
SG11202112391UA (en) 2019-05-31 2021-12-30 Sage Therapeutics Inc Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids

Also Published As

Publication number Publication date
DE2438020A1 (de) 1976-02-26
AT345998B (de) 1978-10-10
GB1512258A (en) 1978-05-24
IL47770A (en) 1978-10-31
US4029777A (en) 1977-06-14
CH611910A5 (OSRAM) 1979-06-29
JPS5141347A (en) 1976-04-07
SE404804B (sv) 1978-10-30
BE832124A (fr) 1976-02-05
SE7508777L (sv) 1976-02-06
AU8351575A (en) 1977-02-03
CA1037027A (en) 1978-08-22
DK344475A (da) 1976-02-06
FR2281123A1 (fr) 1976-03-05
IL47770A0 (en) 1975-10-15
ES439720A1 (es) 1977-03-01
DK136369C (da) 1978-02-27
CS175500B2 (OSRAM) 1977-05-31
HU171684B (hu) 1978-02-28
DD120192A5 (OSRAM) 1976-06-05
NL7509326A (nl) 1976-02-09
ATA600475A (de) 1978-02-15
DK136369B (da) 1977-10-03

Similar Documents

Publication Publication Date Title
CS175500B2 (OSRAM)
FR2257596B1 (OSRAM)
FI752154A7 (OSRAM)
AU496555B2 (OSRAM)
AU495028B2 (OSRAM)
AU8476175A (OSRAM)
AU7205174A (OSRAM)
CS168392B1 (OSRAM)
CS176571B1 (OSRAM)
AU481765A (OSRAM)
AU481606A (OSRAM)
BG19669A1 (OSRAM)
BG19668A1 (OSRAM)
BG19624A1 (OSRAM)
BG19618A1 (OSRAM)
BG19673A1 (OSRAM)
BE836321A (OSRAM)
BE830156A (OSRAM)
AU490706A (OSRAM)
AU482014A (OSRAM)
AU481825A (OSRAM)
BG19712A1 (OSRAM)
DD121696A5 (OSRAM)
DD116904A5 (OSRAM)
DD115527A1 (OSRAM)